Safety, Tolerability, and Pharmacokinetics of EGT710, a Novel Coronavirus M(pro) Inhibitor, in Healthy Adults: A Randomized, Single- and Multiple-Dose Study.
Overview & Synopsis
Open access biomedical research article published in Clin Pharmacol Drug Dev.
Indexed from repository: PubMed Central
(
pmc.ncbi.nlm.nih.gov)
Keyboard Shortcuts:
← / → for pages • + / - for zoom • 0 to fit width
Powered by Mozilla PDF.js v3.11
Document Information
| Document Title | Safety, Tolerability, and Pharmacokinetics of EGT710, a Novel Coronavirus M(pro) Inhibitor, in Healthy Adults: A Randomized, Single- and Multiple-Dose Study. |
|---|---|
| Author / Organization | Oosterhaven JAF, Trolander J, Bebrevska L, Schiller H, Alaybeyoglu B, Gaudet S, Claas A, Balavenkatraman KK, Bergeron R, Duraes FV, Chaperon F, Ghanshani S, Goncalves E, Kovacs SJ |
| Subject & Discipline | Clin Pharmacol Drug Dev |
| Categories | Medicine & Health |
| License / Rights | Open Access / Creative Commons |
| Resource Verification | Listed PDF (Verification Pending) |
| Original Host Website |
PubMed Central
(pmc.ncbi.nlm.nih.gov)
|
| File Format | application/pdf (Portable Document Format) |
| Language | EN |
| Catalog ID | DOC-12543 |
| Original Source Link | Visit Source Page on pmc.ncbi.nlm.nih.gov » |